Evidence map›Paper›PMID 37129613›Full record

ArticleSkeletal radiology2023

Increased

Xiaoli Liu, Shoumei Yan, Xueting Qin, Kai Cheng, Jinsong Zheng, Hongbo Wu, Yuchun Wei, Shuanghu Yuan

Abstract read
PubMed Publisher
In one paragraph

Article in Skeletal radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Evaluating the diagnostic value ofJapanese journal of radiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiaoli LiuDepartment of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Shoumei YanDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Xueting QinDepartment of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Kai ChengDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Jinsong ZhengDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Hongbo WuDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Yuchun WeiDepartment of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. yuchunwei0000@foxmail.com.
Shuanghu YuanDepartment of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. yuanshuanghu@sina.com.
Shandong First Medical University · CNShandong Tumor Hospital · CN

Funding

Bethune Charitable Foundation flzh202116National Natural Science Foundation of China 81872475National Natural Science Foundation of China 82073345Natural Science Foundation of Shandong Province ZR2021QH008
6 · The paper itself

Abstract

objectiveThis study investigated the distribution and characteristics of various bone and joint lesions on

methodsSeventy-four lung cancer patients who underwent

resultsIn 53 patients, a total of 262 lesions presented

conclusionThis study demonstrated that

Indexed as

ArthritisLung NeoplasmsPeriodontitisFluorodeoxyglucose F18HumansPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18Bone metastasesDifferential diagnosisFibroblast activation protein inhibitorLung cancerPET/CT

Identifiers

PMID37129613
OpenAlexW4367668748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.